Investment Trusts

The Biotech Growth Trust PLC

BIOG:LSE

The Biotech Growth Trust PLC

  • Price (GBX)1,195.00
  • Today's Change-15.00 / -1.24%
  • Shares traded74.87k
  • 1 Year change31.75%
  • Beta0.6200
Data delayed at least 20 minutes, as of Feb 06 2026 16:38 GMT.
More ▼
Total returns on £1000
1Y
Fund/benchmarkChange
PriceThe Biotech Growth Trust PLC (Ordinary Share)+34.05%
NAVThe Biotech Growth Trust PLC (Ordinary Share)+25.63%
Morningstar's BenchmarkNASDAQ Biotechnology TR GBP+27.46%

Key statistics

On Friday, The Biotech Growth Trust PLC (BIOG:LSE) closed at 1,195.00, -8.08% below its 52-week high of 1,300.00, set on Jan 23, 2026.
52-week range
Today
612.70Apr 09 20251,300.00Jan 23 2026
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding20.75m
Market cap251.05m GBP
Total assets286.82m GBP
Total expense ratio--
High1,210.00
Low1,175.00
Previous close1,210.00
Average volume59.34k
YTD Change-0.42%
Beta0.6200
Diluted NAV (est)1,297.07
Diluted NAV (last pub)1,254.50
Premium/Discount-5.54%
Net Gearing+8.64%
Data delayed at least 20 minutes, as of Feb 06 2026 16:38 GMT.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.